Immunocore Holdings plc

US$30.99As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMCRHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (7.52%)
Div yield —
ROE (7.87%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM (6.35%)
Mkt cap US$1.596B
ROIC (0.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$40
29.14%
(66.03%)
Sell 1|9|1|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.38
0.41
0.39
0.43
2.47%
12.25%
(0.19%)
14.00%
Revenue$M
90.06
90.49
92.64
95.57
12.01%
7.79%
10.15%
7.47%
Peers (US$1.596B)
Cap (US$)
PE
2.709B
—
2.071B
5.627x
Capital
TTM
5Y
10Y
Leveragex
1.747
(0.188)
(0.183)
EBIT/Intx
0.674
0.393
0.413
Own earn%
(6.35)
(12.67)
(19.43)
Sh yield%
25.22
31.06
31.59
Owners
Insiders/Inst%
6.62
59.89
Short interest%
3.03
SBC / revenue%
4.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
19–28
$1 testx
0.0
Incr. ROIC%
7